LEI 254900UKQHWYZJD22017
NYKODE THERAPEUTICS ASA
Contract awards & public grants
NYKODE THERAPEUTICS ASA — Second generation COVID-19 vaccine on the Vaccibody platform
Norges forskningsråd · NO · Grant · 2021-01-01
NOK 12.49M
NYKODE THERAPEUTICS ASA — Development of a highly efficient and robust manufacturing process for personalised and general DNA vaccines
Norges forskningsråd · NO · Grant · 2020-01-01
NOK 13.35M
NYKODE THERAPEUTICS ASA — Innovasjonstilskudd: Forsknings- og utviklingstilskudd
Innovasjon Norge · NO · Grant · 2019-04-10
€347,826
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.